These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30836941)

  • 1. Herd immunity alters the conditions for performing dose schedule comparisons: an individual-based model of pneumococcal carriage.
    Yang A; Cai F; Lipsitch M
    BMC Infect Dis; 2019 Mar; 19(1):227. PubMed ID: 30836941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial.
    van Gils EJ; Veenhoven RH; Hak E; Rodenburg GD; Bogaert D; Ijzerman EP; Bruin JP; van Alphen L; Sanders EA
    JAMA; 2009 Jul; 302(2):159-67. PubMed ID: 19584345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
    Dagan R; Givon-Lavi N; Porat N; Greenberg D
    Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.
    Ojal J; Hammitt LL; Gaitho J; Scott JAG; Goldblatt D
    Vaccine; 2017 Aug; 35(35 Pt B):4652-4657. PubMed ID: 28739116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage.
    Fleming-Dutra KE; Conklin L; Loo JD; Knoll MD; Park DE; Kirk J; Goldblatt D; Whitney CG; O'Brien KL
    Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S152-60. PubMed ID: 24336057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.
    Nurhonen M; Cheng AC; Auranen K
    PLoS One; 2013; 8(2):e56079. PubMed ID: 23457504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine.
    Cai FY; Fussell T; Cobey S; Lipsitch M
    PLoS Comput Biol; 2018 Oct; 14(10):e1006333. PubMed ID: 30273332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.
    Cheung YB; Zaman SM; Nsekpong ED; Van Beneden CA; Adegbola RA; Greenwood B; Cutts FT
    Pediatr Infect Dis J; 2009 Nov; 28(11):990-5. PubMed ID: 19536041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects.
    Davis SM; Deloria-Knoll M; Kassa HT; O'Brien KL
    Vaccine; 2013 Dec; 32(1):133-45. PubMed ID: 23684824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.
    Tocheva AS; Jefferies JM; Rubery H; Bennett J; Afimeke G; Garland J; Christodoulides M; Faust SN; Clarke SC
    Vaccine; 2011 Jun; 29(26):4400-4. PubMed ID: 21504773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.
    Nicholls TR; Leach AJ; Morris PS
    Vaccine; 2016 Feb; 34(6):703-13. PubMed ID: 26742947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.
    Brandileone MC; Zanella RC; Almeida SCG; Brandao AP; Ribeiro AF; Carvalhanas TMP; Sato H; Andrade AL; Verani JR;
    Vaccine; 2016 Nov; 34(46):5604-5611. PubMed ID: 27692770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rise and fall of pneumococcal serotypes carried in the PCV era.
    Devine VT; Cleary DW; Jefferies JM; Anderson R; Morris DE; Tuck AC; Gladstone RA; O'Doherty G; Kuruparan P; Bentley SD; Faust SN; Clarke SC
    Vaccine; 2017 Mar; 35(9):1293-1298. PubMed ID: 28161425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring the effects of pneumococcal conjugate vaccine (PCV7) on Streptococcus pneumoniae carriage and antibiotic resistance: the Palestinian-Israeli Collaborative Research (PICR).
    Daana M; Rahav G; Hamdan A; Thalji A; Jaar F; Abdeen Z; Jaber H; Goral A; Huppert A; Raz M; Regev-Yochay G;
    Vaccine; 2015 Feb; 33(8):1021-6. PubMed ID: 25593104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model.
    Le Polain De Waroux O; Flasche S; Prieto-Merino D; Goldblatt D; Edmunds WJ
    Pediatr Infect Dis J; 2015 Aug; 34(8):858-64. PubMed ID: 26075814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable dynamics of pneumococcal carriage over a decade in the pre-PCV era.
    Wagner BG; Althouse BM; Givon-Lavi N; Hu H; Dagan R
    Vaccine; 2019 Sep; 37(37):5625-5629. PubMed ID: 31383489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination.
    Väkeväinen M; Soininen A; Lucero M; Nohynek H; Auranen K; Mäkelä PH; Williams G; Käyhty H;
    J Pediatr; 2010 Nov; 157(5):778-83.e1. PubMed ID: 20547399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compared effectiveness of the 7-valent pneumococcal conjugate vaccine in children with the 13-valent vaccine in adults.
    Gaillat J
    Med Mal Infect; 2013 Jun; 43(6):215-21. PubMed ID: 23769155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carriage of Streptococcus pneumoniae in Taiwan before and after the introduction of a conjugate vaccine.
    Kuo CY; Hwang KP; Hsieh YC; Cheng CH; Huang FL; Shen YH; Huang YC; Chiu CH; Chen PY; Lin TY
    Vaccine; 2011 Jul; 29(32):5171-7. PubMed ID: 21621578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.